Autoimmune Mechanisms and Treatment Approaches in Graves' Disease-Induced Hyperthyroidism: A Comprehensive Review

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 23

فایل این مقاله در 18 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJABBR-14-1_005

تاریخ نمایه سازی: 21 آبان 1405

چکیده مقاله:

Graves' disease represents the predominant etiology of hyperthyroidism globally, affecting ۶۰-۸۰% of hyperthyroid cases worldwide. This autoimmune disorder results from thyroid-stimulating immunoglobulins (TSI) inappropriately activating thyroid-stimulating hormone receptors (TSHR), leading to excessive thyroid hormone production and subsequent metabolic dysfunction. The disease predominantly affects women of reproductive age, with a female-to-male ratio of ۵-۱۰:۱, and exhibits significant geographical variation in prevalence and clinical presentation. This comprehensive review aims to provide an in-depth analysis of the complex autoimmune mechanisms underlying Graves' disease pathogenesis and critically evaluate current therapeutic modalities alongside emerging treatment strategies that target specific immunological pathways. A systematic literature review was conducted using PubMed, Scopus, and Web of Science databases, focusing on peer-reviewed articles published between ۲۰۱۰ and ۲۰۲۴. Search terms included "Graves' disease," "hyperthyroidism," "autoimmune thyroid," "TSH receptor antibodies," "immunomodulatory therapy," and "thyroid autoimmunity." Articles were screened for relevance and methodological quality. The pathophysiology involves complex molecular interactions between genetic predisposition (HLA-DR۳, CTLA-۴ polymorphisms), environmental triggers including iodine excess and stress, and immune system dysregulation. CD۱۱c+ B cells have emerged as novel therapeutic targets, demonstrating strong correlation with serum TRAb levels and disease activity markers. Current treatment modalities include antithyroid drugs (methimazole, propylthiouracil), radioiodine therapy, and surgical thyroidectomy. Emerging therapeutic approaches focus on TRAb-targeting strategies, including novel TSHR antagonists (K۱-۷۰) and precision medicine strategies that incorporate detailed immunophenotyping profiles. Recent advances in understanding immune mechanisms have opened promising new therapeutic avenues. TRAb-targeted biologics and personalized precision medicine approaches show significant potential for individualized treatment strategies, potentially improving long-term remission rates and substantially reducing disease recurrence in comprehensive Graves' disease management.

نویسندگان

- -

Department of Biochemistry, Faculty of Basic Medical Sciences, University of Lagos, Idi-Araba, Nigeria

- -

Department of Biochemistry, Faculty of Biosciences, Federal University Wukari, Taraba State, Nigeria

- -

Department of Biochemistry, Faculty of Biosciences, Federal University Wukari, Taraba State, Nigeria

- -

Departments of Medicine, College of Medicine, University of Gullas, Cebu, Philippines

- -

Department of Medicine and Surgery, Faculty of Clinical sciences, University of Ibadan, Ibadan, Nigeria

- -

Department of Medicine and Surgery, College of Medicine, Kursk State Medical University, Kursk City, Russia

- -

Department of Internal Medicine, Internal Medicine and Public Health, Federal Medical Center, Ebute Metta, Lagos, Nigeria

- -

Department of Pharmacognosy, Faculty of Pharmacy, University of Lagos. Idia-Araba, Nigeria

- -

Department of Internal Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria

- -

Department of Internal Medicine and Surgery, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi-Araba, Lagos, Nigeria

- -

Department of Computer Science, Faculty of Science and Technology, Babcock University, Ilisan-Remo Ogun State, Nigeria

- -

Department of Microbiology, Faculty of Biological Sciences, University of Nigeria Nsukka, Nsukka, Nigeria

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • . Hussain, Y.S., Hookham, J.C., Allahabadia, A., Balasubramanian, S.P., Epidemiology, ...
  • . Majid, S., Graves' disease: Pathophysiology, genetics and management. Graves' ...
  • . Pokhrel B, Bhusal K. Graves disease. In: StatPearls. Treasure ...
  • . Stasiak, M., Stasiak, B., Zawadzka-Starczewska, K., Lewiński, A., Significance ...
  • . Bartalena, L., Tanda, M.L., Current concepts regarding graves’ orbitopathy. ...
  • . Cao, Y., Zhao, X., You, R., Zhang, Y., Qu, ...
  • . Diana, T., Olivo, P.D., Kahaly, G.J., Thyrotropin receptor blocking ...
  • . Kahaly, G.J., Diana, T., Tsh receptor antibody functionality and ...
  • . Pirahanchi Y, Toro F, Jialal I. Physiology, thyroid stimulating ...
  • Starczewska, K., Tymoniuk, B., Stasiak, B., Lewiński, A., Stasiak, M., ...
  • . Li, Y., Yao, Y., Yang, M., Shi, L., Li, ...
  • . Huang, X., Liu, G., Mei, S., Cai, J., Rao, ...
  • . Cheung, Y.K., Cheng, S.H., Chan, E.J., Lo, S.V., Ng, ...
  • . Hansen, M., Cheever, A., Weber, K.S., O’Neill, K.L., Characterizing ...
  • . Hammad, H., Lambrecht, B.N., The basic immunology of asthma. ...
  • . Qin, Y., Gao, C., Luo, J., Metabolism characteristics of ...
  • . Bogović Crnčić, T., Girotto, N., Ilić Tomaš, M., Krištofić, ...
  • . Yamakawa, H., Kato, T.S., Noh, J.Y., Yuasa, S., Kawamura, ...
  • . Aoun, T., Danielova Gueorguieva, D., Wu, K.Y., Orbital inflammation ...
  • . Van Le, C., Linh, P.N.T., Thi, X.N., Vo, T.T., ...
  • . Abdi, H., Amouzegar, A., Azizi, F., Antithyroid drugs. Iranian ...
  • . Awosika AO, Singh G, Correa R. Methimazole. InStatPearls, ۲۰۲۳ ...
  • . Kim, H.J., Long-term management of graves disease: A narrative ...
  • . DeGroot LJ. Diagnosis and treatment of Graves' disease. Endotext. ...
  • . Padda IS, Nguyen M. Radioactive iodine therapy. Treasure Island ...
  • . Ponto, K.A., Zang, S., Kahaly, G.J., The tale of ...
  • . Jung, C.-H., Treatment of graves’ disease: Faster remission or ...
  • . Biello A, Kinberg EC, Menon G, Wirtz ED. Thyroidectomy. ...
  • . Lanzolla, G., Sabini, E. News in graves’ orbitopathy: Patients ...
  • . Ugradar, S., Malkhasyan, E., Douglas, R.S., Teprotumumab for the ...
  • . Salvi, M., Vannucchi, G., Currò, N., Campi, I., Covelli, ...
  • . Lane, L.C., Cheetham, T.D., Perros, P., Pearce, S.H., New ...
  • . Furmaniak, J., Sanders, J., Sanders, P., Li, Y., Rees ...
  • . Mozzi, A., Pontremoli, C., Sironi, M., Genetic susceptibility to ...
  • . Moledina, M., Damato, E.M., Lee, V., The changing landscape ...
  • . Smith, T.J., Hegedüs, L., Graves’ disease. New England Journal ...
  • . Rincon-Arevalo, H., Wiedemann, A., Stefanski, A.-L., Lettau, M., Szelinski, ...
  • . Huber, A., Menconi, F., Corathers, S., Jacobson, E.M., Tomer, ...
  • . Kahaly, G.J., Immunotherapies for thyroid eye disease. Current Opinion ...
  • . Ross, D.S., Burch, H.B., Cooper, D.S., Greenlee, M.C., Laurberg, ...
  • . Abraham, P., Avenell, A., McGeoch, S.C., Clark, L.F., Bevan, ...
  • . Cooper, D.S., Antithyroid drugs. New England Journal of Medicine, ...
  • . Association, A.T., Hyperthyroidism, A.A.o.C.E.T.o., Thyrotoxicosis, O.C.o., Bahn, R.S., Burch, ...
  • . Kim MY, Kim JH, Cho MH, Choi YH, Kim ...
  • . Razavi CR, Tufano RP, Russell JO. Completion thyroidectomy: what ...
  • نمایش کامل مراجع